Effectiveness and safety of direct oral anticoagulants in atrial fibrillation patients switched from vitamin K antagonists: A systematic review and meta‐analysis.

MLA

Hellfritzsch, Maja, et al. “Effectiveness and Safety of Direct Oral Anticoagulants in Atrial Fibrillation Patients Switched from Vitamin K Antagonists: A Systematic Review and Meta‐analysis.” Basic & Clinical Pharmacology & Toxicology, vol. 126, no. 1, Jan. 2020, pp. 21–31. EBSCOhost, https://doi.org/10.1111/bcpt.13283.

APA

Hellfritzsch, M., Adelborg, K., Damkier, P., Paaske Johnsen, S., Hallas, J., Pottegård, A., & Grove, E. L. (2020). Effectiveness and safety of direct oral anticoagulants in atrial fibrillation patients switched from vitamin K antagonists: A systematic review and meta‐analysis. Basic & Clinical Pharmacology & Toxicology, 126(1), 21–31. https://doi.org/10.1111/bcpt.13283

Chicago

Hellfritzsch, Maja, Kasper Adelborg, Per Damkier, Søren Paaske Johnsen, Jesper Hallas, Anton Pottegård, and Erik Lerkevang Grove. 2020. “Effectiveness and Safety of Direct Oral Anticoagulants in Atrial Fibrillation Patients Switched from Vitamin K Antagonists: A Systematic Review and Meta‐analysis.” Basic & Clinical Pharmacology & Toxicology 126 (1): 21–31. doi:10.1111/bcpt.13283.